SiteOne Therapeutics
SiteOne Therapeutics is a biopharmaceutical company that develops novel therapeutics and diagnostics. They develop products that safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.
Domain
siteonetherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$100.0M
Founded
2009
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does SiteOne Therapeutics use?+
SiteOne Therapeutics uses 9 technologies including Adobe Client Data Layer, Adobe Experience Manager Franklin, Adobe Experience Platform Launch.
What industry is SiteOne Therapeutics in?+
SiteOne Therapeutics operates in the Biotechnology industry.
Where is SiteOne Therapeutics based?+
SiteOne Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026